Importantly, treatment with a single dose of Gal-9 eliminated the CD34+ AML cells even after ‘long-term’ incubation of up to 7 days, whereas CB-derived CD34+ stem cells remained unaffected, as shown by microscopy images (Fig. 2H). Here, LGALS9 is linked to acute myeloid leukemia.